ZA988052B - Transdermal therapeutic system comprising the active substance scopolamine base - Google Patents
Transdermal therapeutic system comprising the active substance scopolamine baseInfo
- Publication number
- ZA988052B ZA988052B ZA988052A ZA988052A ZA988052B ZA 988052 B ZA988052 B ZA 988052B ZA 988052 A ZA988052 A ZA 988052A ZA 988052 A ZA988052 A ZA 988052A ZA 988052 B ZA988052 B ZA 988052B
- Authority
- ZA
- South Africa
- Prior art keywords
- active substance
- transdermal therapeutic
- layer
- therapeutic system
- scopolamine base
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19738643A DE19738643C2 (de) | 1997-09-04 | 1997-09-04 | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA988052B true ZA988052B (en) | 1999-03-05 |
Family
ID=7841162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA988052A ZA988052B (en) | 1997-09-04 | 1998-09-03 | Transdermal therapeutic system comprising the active substance scopolamine base |
Country Status (22)
Country | Link |
---|---|
US (1) | US6537571B1 (cs) |
EP (1) | EP1011674B1 (cs) |
JP (1) | JP3834202B2 (cs) |
KR (1) | KR100549846B1 (cs) |
AT (1) | ATE214606T1 (cs) |
AU (1) | AU738009B2 (cs) |
CA (1) | CA2300339C (cs) |
DE (2) | DE19738643C2 (cs) |
DK (1) | DK1011674T3 (cs) |
ES (1) | ES2174492T3 (cs) |
HK (1) | HK1032194A1 (cs) |
HU (1) | HUP0003480A3 (cs) |
ID (1) | ID24266A (cs) |
IL (1) | IL134418A (cs) |
NO (1) | NO20000894D0 (cs) |
NZ (1) | NZ502873A (cs) |
PL (1) | PL339226A1 (cs) |
PT (1) | PT1011674E (cs) |
SK (1) | SK3052000A3 (cs) |
TR (1) | TR200000407T2 (cs) |
WO (1) | WO1999011265A1 (cs) |
ZA (1) | ZA988052B (cs) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050013957A1 (en) * | 2003-07-15 | 2005-01-20 | Boris Leschinsky | Disposable medical article with multiple adhesives for skin attachment |
DE102004020463A1 (de) * | 2004-04-26 | 2005-11-10 | Grünenthal GmbH | Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel |
DE102004044578A1 (de) | 2004-09-13 | 2006-03-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht |
US20070010550A1 (en) * | 2005-07-08 | 2007-01-11 | The Board Of Regents Of The University Of Texas | Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia |
MX2008010934A (es) * | 2006-02-27 | 2008-10-30 | Noven Pharma | Sistema terapeutico transdermico que contiene escopolamina. |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
KR101572721B1 (ko) | 2013-10-14 | 2015-11-27 | 주식회사 엘지생활건강 | 히오신을 유효 성분으로 함유하는 피부 건조증 또는 피부 장벽 기능 개선용 조성물 |
JP2018514511A (ja) * | 2015-04-14 | 2018-06-07 | アトッサ ジェネティックス インク. | 乳房障害とエストロゲン関連障害の処置のための組成物と方法 |
CA3061284A1 (en) * | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing scopolamine and silicone acrylic hybrid polymer |
DE102018118507A1 (de) * | 2018-07-31 | 2020-02-06 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US35474A (en) * | 1862-06-03 | Improved rocket-harpoon | ||
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3903880A (en) * | 1972-08-17 | 1975-09-09 | Alza Corp | Intrauterine device for managing the reproductive process |
US4573996A (en) * | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4655767A (en) * | 1984-10-29 | 1987-04-07 | Dow Corning Corporation | Transdermal drug delivery devices with amine-resistant silicone adhesives |
US4832953A (en) * | 1987-08-13 | 1989-05-23 | Alza Corporation | Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3908431A1 (de) * | 1989-03-15 | 1990-09-27 | Lohmann Therapie Syst Lts | Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung |
EP0671176B1 (en) * | 1993-09-30 | 2001-06-06 | Takiron Co. Ltd. | Percutaneously absorbable preparation |
US5714162A (en) * | 1994-09-16 | 1998-02-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Scopolamine patch |
DE4438989C2 (de) * | 1994-09-16 | 1999-02-25 | Lohmann Therapie Syst Lts | Scopolaminpflaster |
ATE207348T1 (de) * | 1995-12-01 | 2001-11-15 | Alza Corp | Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix |
-
1997
- 1997-09-04 DE DE19738643A patent/DE19738643C2/de not_active Expired - Fee Related
-
1998
- 1998-08-18 PT PT98946364T patent/PT1011674E/pt unknown
- 1998-08-18 DK DK98946364T patent/DK1011674T3/da active
- 1998-08-18 JP JP2000508368A patent/JP3834202B2/ja not_active Expired - Lifetime
- 1998-08-18 ID IDW20000299A patent/ID24266A/id unknown
- 1998-08-18 IL IL13441898A patent/IL134418A/en not_active IP Right Cessation
- 1998-08-18 TR TR2000/00407T patent/TR200000407T2/xx unknown
- 1998-08-18 NZ NZ502873A patent/NZ502873A/en unknown
- 1998-08-18 WO PCT/EP1998/005224 patent/WO1999011265A1/de active IP Right Grant
- 1998-08-18 EP EP98946364A patent/EP1011674B1/de not_active Expired - Lifetime
- 1998-08-18 KR KR1020007002299A patent/KR100549846B1/ko not_active IP Right Cessation
- 1998-08-18 PL PL98339226A patent/PL339226A1/xx unknown
- 1998-08-18 DE DE59803454T patent/DE59803454D1/de not_active Expired - Lifetime
- 1998-08-18 ES ES98946364T patent/ES2174492T3/es not_active Expired - Lifetime
- 1998-08-18 HU HU0003480A patent/HUP0003480A3/hu unknown
- 1998-08-18 US US09/485,912 patent/US6537571B1/en not_active Expired - Lifetime
- 1998-08-18 SK SK305-2000A patent/SK3052000A3/sk unknown
- 1998-08-18 AU AU93434/98A patent/AU738009B2/en not_active Ceased
- 1998-08-18 AT AT98946364T patent/ATE214606T1/de active
- 1998-08-18 CA CA002300339A patent/CA2300339C/en not_active Expired - Lifetime
- 1998-09-03 ZA ZA988052A patent/ZA988052B/xx unknown
-
2000
- 2000-02-23 NO NO20000894A patent/NO20000894D0/no not_active Application Discontinuation
- 2000-12-23 HK HK00108393A patent/HK1032194A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL134418A0 (en) | 2001-04-30 |
DE19738643A1 (de) | 1999-03-11 |
WO1999011265A1 (de) | 1999-03-11 |
DE19738643C2 (de) | 2001-10-04 |
PL339226A1 (en) | 2000-12-04 |
DK1011674T3 (da) | 2002-07-08 |
AU738009B2 (en) | 2001-09-06 |
ATE214606T1 (de) | 2002-04-15 |
US6537571B1 (en) | 2003-03-25 |
CA2300339C (en) | 2007-07-17 |
ES2174492T3 (es) | 2002-11-01 |
HK1032194A1 (en) | 2001-07-13 |
PT1011674E (pt) | 2002-08-30 |
JP2001514226A (ja) | 2001-09-11 |
EP1011674B1 (de) | 2002-03-20 |
IL134418A (en) | 2004-02-19 |
NO20000894L (no) | 2000-02-23 |
KR100549846B1 (ko) | 2006-02-06 |
AU9343498A (en) | 1999-03-22 |
HUP0003480A2 (hu) | 2001-02-28 |
CA2300339A1 (en) | 1999-03-11 |
HUP0003480A3 (en) | 2001-03-28 |
DE59803454D1 (de) | 2002-04-25 |
JP3834202B2 (ja) | 2006-10-18 |
EP1011674A1 (de) | 2000-06-28 |
ID24266A (id) | 2000-07-13 |
NZ502873A (en) | 2001-07-27 |
TR200000407T2 (tr) | 2000-08-21 |
SK3052000A3 (en) | 2000-12-11 |
KR20010023647A (ko) | 2001-03-26 |
NO20000894D0 (no) | 2000-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2302601A1 (en) | Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience | |
IE59729B1 (en) | Therapeutic system, process for its production and its use | |
JPS6468314A (en) | Transdermal drug administration system containing two kind of permeation accelerators | |
MY132338A (en) | Estradiol-containing patch | |
CA2030178A1 (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
HK1032194A1 (en) | Transdermal therapeutic system containing the active substance scopolamine base | |
CA2338859A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
CA2335582A1 (en) | Transdermal therapeutic system containing hormones and crystallization inhibitors | |
CA2490573A1 (en) | Improved transdermal delivery system | |
CA2403949A1 (en) | Transdermal therapeutic system for the delivery of lerisetron | |
AU2001230193A1 (en) | Transdermal therapeutic system for the administration of zaleplon | |
MY110391A (en) | Nitroglycerin-containing patch, a process for the production and the use thereof |